Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan1309-1312
Roles of Eph/ephrin bidirectional signaling during injury and recovery of the central nervous system1313-1321
Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's disease1332-1337
Targeting the mitochondrial permeability transition pore in traumatic central nervous system injury1338-1341
Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration:neurophysiological insights into stem progenitor cell neurogenesis within a host environment1350-1351